| Proteogenomic integration reveals therapeutic targets in breast cancer xenografts K Huang, S Li, P Mertins, S Cao, HP Gunawardena, KV Ruggles, ... Nature communications 8 (1), 14864, 2017 | 151 | 2017 |
| Microscaled proteogenomic methods for precision oncology S Satpathy, EJ Jaehnig, K Krug, BJ Kim, AB Saltzman, DW Chan, ... Nature communications 11 (1), 532, 2020 | 98 | 2020 |
| Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ... Cell reports 24 (6), 1434-1444. e7, 2018 | 97 | 2018 |
| Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer S Haricharan, N Punturi, P Singh, KR Holloway, M Anurag, J Schmelz, ... Cancer discovery 7 (10), 1168-1183, 2017 | 75 | 2017 |
| gpGrouper: a peptide grouping algorithm for gene-centric inference and quantitation of bottom-up proteomics data AB Saltzman, M Leng, B Bhatt, P Singh, DW Chan, L Dobrolecki, ... Molecular & Cellular Proteomics 17 (11), 2270-2283, 2018 | 74 | 2018 |
| Neurofibromin is an estrogen receptor-α transcriptional co-repressor in breast cancer ZY Zheng, M Anurag, JT Lei, J Cao, P Singh, J Peng, H Kennedy, ... Cancer cell 37 (3), 387-402. e7, 2020 | 67 | 2020 |
| The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells IL Bado, W Zhang, J Hu, Z Xu, H Wang, P Sarkar, L Li, YW Wan, J Liu, ... Developmental cell 56 (8), 1100-1117. e9, 2021 | 65 | 2021 |
| Comparative analysis of cytotoxic effect of aqueous cinnamon extract from Cinnamomum zeylanicum bark with commercial cinnamaldehyde on various cell lines R Singh, SJ Koppikar, P Paul, S Gilda, AR Paradkar, R Kaul-Ghanekar Pharmaceutical biology 47 (12), 1174-1179, 2009 | 53 | 2009 |
| Twist1 activation in muscle progenitor cells causes muscle loss akin to cancer cachexia P Parajuli, S Kumar, A Loumaye, P Singh, S Eragamreddy, TL Nguyen, ... Developmental cell 45 (6), 712-725. e6, 2018 | 47 | 2018 |
| DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer R Matsunuma, DW Chan, BJ Kim, P Singh, A Han, AB Saltzman, C Cheng, ... Proceedings of the National Academy of Sciences 115 (51), E11978-E11987, 2018 | 44 | 2018 |
| TGIF 1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma P Parajuli, P Singh, Z Wang, L Li, S Eragamreddi, S Ozkan, O Ferrigno, ... The EMBO journal 38 (13), e101067, 2019 | 25 | 2019 |
| Transcriptional reprogramming differentiates active from inactive ESR1 fusions in endocrine therapy-refractory metastatic breast cancer X Gou, M Anurag, JT Lei, BJ Kim, P Singh, S Seker, D Fandino, A Han, ... Cancer research 81 (24), 6259-6272, 2021 | 13 | 2021 |
| Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun 8: 14864 KL Huang, S Li, P Mertins, S Cao, HP Gunawardena, KV Ruggles, ... | 6 | 2017 |
| Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer X Gou, BJ Kim, M Anurag, JT Lei, MN Young, MV Holt, D Fandino, ... Cancer research 83 (19), 3237-3251, 2023 | 3 | 2023 |
| Proteomics: A prospective new tool in forensic investigations S Kumar, P Singh Forensic Sci. Rev. 33 (2), 145-150, 2021 | 3 | 2021 |
| Kinase inhibitor pulldown assay (KiP) for clinical proteomics AB Saltzman, DW Chan, MV Holt, J Wang, EJ Jaehnig, M Anurag, P Singh, ... Clinical Proteomics 21 (1), 3, 2024 | 2 | 2024 |
| Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment BJ Kim, ZY Zheng, JT Lei, MV Holt, A Chen, J Peng, D Fandino, P Singh, ... Cancer Research Communications 3 (7), 1366-1377, 2023 | 2 | 2023 |
| Abstract PD8-02: kinome profiling of ER+ breast cancer PDXs identifies PKMYT1 as a marker of hormone independent growth and poor outcome A Chen, BJ Kim, DW Chan, P Singh, LE Dobrolecki, JT Lei, S Li, AL Welm, ... Cancer Research 81 (4_Supplement), PD8-02-PD8-02, 2021 | 1 | 2021 |
| Phenotypic plasticity of ER+ breast cancer in the bone microenvironment IL Bado, H Wang, J Hu, P Sarkar, J Liu, Z Gugala, Z Xu, W Zhang, W Wu, ... bioRxiv, 2020.11. 14.383000, 2020 | 1 | 2020 |
| NF1 as an estrogen receptor-α co-repressor in breast cancer EC Chang, zeyi Zheng, M Anurag, J Gao, B Cakar, X Du, J Li, P Lavere, ... Cancer Research 78 (13_Supplement), 1814-1814, 2018 | 1 | 2018 |
